Df Dent & CO Inc Abcam PLC Transaction History

Df Dent & CO Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$12.62 - $24.47 $175,645 - $340,573	13,918 Added 1.69%	838,114 $20.5 Million
Q1 2023 May 15, 2023	BUY	$12.98 - $17.1 $797,166 - $1.05 Million	61,415 Added 8.05%	824,196 $11.1 Million
Q4 2022 Feb 15, 2023	SELL	$13.92 - $17.0 $706,356 - $862,648	-50,744 Reduced 6.24%	762,781 $11.9 Million
Q3 2022 Nov 14, 2022	SELL	$13.36 - $16.75 $42,057 - $52,729	-3,148 Reduced 0.39%	813,525 $12.2 Million
Q2 2022 Aug 15, 2022	BUY	$12.69 - $19.25 $909,758 - $1.38 Million	71,691 Added 9.62%	816,673 $11.8 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.89 $68,510 - $105,593	4,420 Added 0.6%	744,982 $13.6 Million
Q4 2021 Feb 14, 2022	BUY	$20.04 - $23.84 $262,764 - $312,590	13,112 Added 1.8%	740,562 $17.4 Million
Q3 2021 Nov 15, 2021	BUY	$17.38 - $21.54 $2.12 Million - $2.63 Million	122,038 Added 20.16%	727,450 $14.7 Million
Q2 2021 Aug 16, 2021	BUY	$18.47 - $22.11 $11.2 Million - $13.4 Million	605,412 New	605,412 $11.5 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Df Dent & CO Inc with notifications on news.